65,437 trials
Tuberculosis
Primary: Area Under the Plasma Drug Concentration (AUC) From Time Zero Extrapolated to Infinity (AUC[0-inf]) After a Single Dose of EE and LNG — 627.11; 552.01; 24651.76…
Lung Neoplasms · Non-Small-Cell Lung Carcinoma
Primary: Overall Survival (OS) in Participants With PD-L1 TPS ≥50% — 15.7; 20.3 Months — p=0.6712
Alzheimer Disease · Dementia
Primary: Hospital Transfers — 1.2; 1.3 number of hospital transfers — p=0.3313
Irritability Associated With Autism Spectrum Disorder
Primary: Change From Baseline at Week 6 in Caregiver-rated Aberrant Behavior Checklist Irritability (ABC-I) Subscale Score — -9.6; -11.2; -11.2 score on a scale — p=0.2986
Follicular Thyroid Cancer · Insular Thyroid Cancer · Papillary Thyroid Cancer
Primary: Overall Objective Response Rate, Defined as the Proportion of Patients Who Have a Minor Response (MR), Partial Response (PR), or Complete Response(CR)Assessed According…
Advanced Solid Tumor
Primary: Safety Run-in: Number of Participants With Adverse Events (AEs) — 6; 4; 0 Participants
Opioid Overdose · Drug Overdose
Primary: Number of People Identified Has Having One or More Overdose Among RAPIDS Trial Participants — 48; 36 Participants
Endometrial Cancer
Primary: Change in Proliferative Markers in Endometrium Before and After HIIT Exercises — 21.7; 15.1; 21.7; 20.2 Percentage of cells expressing Ki67
Autism Spectrum Disorder
Primary: Diagnostic Certainty: Tele-assessment — 3.07; 2.85 score on a scale (range 1-4)
Anemia, Iron Deficiency
Primary: Ratio of Maximum Serum Concentration (Cmax) of Total Iron in Fasted Condition — 69.94 ratio
Myopia
Primary: The Rate of Serious Adverse Events at the Subject Level — 0 Participants
Post Traumatic Stress Disorder
Primary: Change in PTSD Symptoms as Assessed by the Impact of Event Scale — -.383; 6.43; -3.18; -2.11 score on a scale — p=<0.05
Tobacco Smoking
Primary: Provider (Staff) Knowledge of Smoking Cessation Treatment as Assessed by a 16-item Scale — 13.8; 14.2 score on a scale
Stress, Psychological
Primary: N-back Task (Working Memory) — 827.50; 844.26; 832.60 Milliseconds
Atopic Dermatitis
Primary: Number of Participants With Any Treatment-emergent Adverse Event (TEAE) — 4; 7 Participants